|
PEX13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.73388999999968E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.79969999972663E-07 |
| Normal-vs-Stage2 |
2.282200E-01 |
| Normal-vs-Stage3 |
1.045790E-01 |
| Normal-vs-Stage4 |
2.459000E-01 |
| Stage1-vs-Stage2 |
1.557760E-01 |
| Stage1-vs-Stage3 |
1.603040E-01 |
| Stage1-vs-Stage4 |
5.586800E-01 |
| Stage2-vs-Stage3 |
8.787400E-01 |
| Stage2-vs-Stage4 |
7.220800E-01 |
| Stage3-vs-Stage4 |
7.909400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.37100000000301E-05 |
| Normal-vs-AfricanAmerican |
2.428700E-04 |
| Normal-vs-Asian |
3.366200E-01 |
| Caucasian-vs-AfricanAmerican |
6.944200E-01 |
| Caucasian-vs-Asian |
8.509400E-01 |
| AfricanAmerican-vs-Asian |
7.144400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.15599999964233E-07 |
| Normal-vs-Female |
2.226400E-01 |
| Male-vs-Female |
7.056500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.637600E-04 |
| Normal-vs-Extreme_Weight |
2.30169999726471E-08 |
| Normal-vs-Obese |
2.101600E-02 |
| Normal-vs-Extreme_Obese |
7.184600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.155600E-01 |
| Normal_Weight-vs-Obese |
2.598400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.323350E-01 |
| Extreme_Weight-vs-Obese |
3.182000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.529900E-02 |
| Obese-vs-Extreme_Obese |
4.680000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.883600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.157000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.21239999995026E-06 |
| Normal-vs-Age(81-100Yrs) |
2.255900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.347780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.693900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.554500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.174350E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.041800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.440400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.96480000000032E-05 |
| Normal-VS-Type2 PRCC |
3.22480000003456E-06 |
| Normal-VS-KIRP CIMP |
4.924200E-02 |
| Normal-VS-Unclassified PRCC |
1.105690E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.596400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.100900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.966200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.65999999996092E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
2.763800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.973700E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.53110999999706E-05 |
| Normal-vs-N1 |
9.961600E-01 |
| Normal-vs-N2 |
8.184600E-01 |
| N0-vs-N1 |
2.593600E-02 |
| N0-vs-N2 |
9.568100E-02 |
| N1-vs-N2 |
9.262400E-01 |
|
|
